Differentiate from competitors and impact patient care

Impact your revenue and expand your service offering

With millions of diagnostics tests run every day, labs have become one of the largest data providers in today’s healthcare industry. In fact, 60-70% of medical decisions are impacted by diagnostic data.1 We want to help elevate the value of your lab.

Differentiate from competitors and impact patient care

Impact your revenue and expand your service offering

With millions of diagnostics tests run every day, labs have become one of the largest data providers in today’s healthcare industry. In fact, 60-70% of medical decisions are impacted by diagnostic data.1 We want to help elevate the value of your lab.

Our navify solutions enable you to differentiate your lab from competitors:

  • Tap into new sources of revenue and expand your service offering
  • Drive additional medical insights with lab data and help improve patient care
  • Enable confident care decisions
  • Provide customers with cutting-edge diagnostic algorithms seamlessly integrated into their clinical workflows

Get to know our navify Diagnostics portfolio*

From advanced digital pathology and sequencing solutions to easily accessible diagnostic algorithms, our solutions allow you to provide decision support to medical staff and to get more medical insights out of lab data.

navify Digital Pathology helps us identify patients who can benefit from new immunotherapies.

Mamatha Chivukula, MD, FASCP
Mills-Peninsula Hospital (Sutter Health Group)

Explore
more

Learn how navify Mutation Profiler*** empowers next-generation sequencing clinical and research labs with actionable information

Read more

Learn how navify Digital Pathology**** empowers the future of pathology

Read more

  1. Rohr UP, Binder C, Dieterle T, Giusti F, Messina CG, Toerien E, Moch H, Schäfer HH. The value of in vitro diagnostic testing in medical practice: a status report. PloS one. 2016 Mar 4;11(3):e0149856.

*Not all products of this product portfolio are intended or approved for diagnostic use

**Individual lab results may vary, and testimonials are not claimed to represent typical results. All testimonials are real participants, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results.

***navify Mutation Profiler is CE-IVD. In the US, navify Mutation Profiler is Research Use Only (RUO). Not for use in diagnostic procedures or decisions.

****If using the product with digital pathology algorithms, refer to the specific algorithm user guide for regulatory classification.Roche uPath enterprise software is CE-IVD and RUO in the US and EMEA/LATAM through our USA and Germany instances. Subject to data residency requirements of individual countries.